Aspirin use reduces the risk of death in hospitalized COVID-19 patients.

According to a new study led by researchers, hospitalized COVID-19 patients who were taking a daily low-dose aspirin to protect against cardiovascular disease had a significantly lower risk of complications and death compared to those who were not taking aspirin at the University of Maryland School of Medicine (UMSOM). Aspirin takers were less likely to be placed in